Your browser doesn't support javascript.
loading
Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial.
Eikelboom, John W; Bosch, Jacqueline; Connolly, Stuart J; Tyrwitt, Jessica; Fox, Keith A A; Muehlhofer, Eva; Neumann, Christoph; Tasto, Christoph; Bangdiwala, Shrikant I; Diaz, Rafael; Alings, Marco; Dagenais, Gilles R; Leong, Darryl P; Lonn, Eva M; Avezum, Alvaro; Piegas, Leopoldo S; Widimsky, Petr; Parkhomenko, Alexander N; Bhatt, Deepak L; Branch, Kelley R H; Probstfield, Jeffrey L; Lopez-Jaramillo, Patricio; Rydén, Lars; Pogosova, Nana; Keltai, Katalin; Keltai, Matyas; Ertl, Georg; Stoerk, Stefan; Dans, Antonio L; Lanas, Fernando; Liang, Yan; Zhu, Jun; Torp-Pedersen, Christian; Maggioni, Aldo P; Commerford, Patrick J; Guzik, Tomasz J; Vanassche, Thomas; Verhamme, Peter; O'Donnell, Martin; Tonkin, Andrew M; Varigos, John D; Vinereanu, Dragos; Felix, Camillo; Kim, Jae-Hyung; Ibrahim, Khairul S; Lewis, Basil S; Metsarinne, Kaj P; Aboyans, Victor; Steg, Phillippe Gabriel; Hori, Masatsugu.
Affiliation
  • Eikelboom JW; Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton General Hospital, 237 Barton Street East, Hamilton Canada.
  • Bosch J; Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton General Hospital, 237 Barton Street East, Hamilton Canada.
  • Connolly SJ; School of Rehabilitation Science, McMaster University, Hamilton, Canada.
  • Tyrwitt J; Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton General Hospital, 237 Barton Street East, Hamilton Canada.
  • Fox KAA; Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton General Hospital, 237 Barton Street East, Hamilton Canada.
  • Muehlhofer E; Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
  • Neumann C; Bayer AG Pharmaceuticals, Research & Development, Wuppertal, Germany.
  • Tasto C; Bayer AG Pharmaceuticals, Research & Development, Wuppertal, Germany.
  • Bangdiwala SI; Bayer AG Pharmaceuticals, Research & Development, Wuppertal, Germany.
  • Diaz R; Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton General Hospital, 237 Barton Street East, Hamilton Canada.
  • Alings M; Estudios Clínicos Latino América and Instituto Cardiovascular de Rosario, Rosaria, Argentina.
  • Dagenais GR; Division of Cardiology, Amphia ziekenhuis, Breda, Netherlands and Werkgroep Cardiologische centra Nederland (WCN), Utrecht, the Netherlands.
  • Leong DP; Institut universitaire de cardiologie et de pneumologie de Québec, Québec, QC, Canada.
  • Lonn EM; Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton General Hospital, 237 Barton Street East, Hamilton Canada.
  • Avezum A; Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton General Hospital, 237 Barton Street East, Hamilton Canada.
  • Piegas LS; International Research Center, Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.
  • Widimsky P; Research Institute, HCor, Hospital do Coração, São Paulo, Brazil.
  • Parkhomenko AN; Cardiocenter, University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Bhatt DL; Emergency Cardiology Dept., National Scientific Center Institute of Cardiology, Kyiv, Ukraine.
  • Branch KRH; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Probstfield JL; University of Washington Medical Centre, Division of Cardiology, Seattle, WA, USA.
  • Lopez-Jaramillo P; University of Washington SOM, Division of Cardiology/Department of Medicine, Seattle WA, USA.
  • Rydén L; Research Institute, Fundación Oftalmológica de Santander (FOSCAL)-Bucaramanga, Bucaramanga, Colombia.
  • Pogosova N; Department of Medicine K2, Karolinska Institutet, Stockholm, Sweden.
  • Keltai K; National Medical Research Center of Cardiology, Ministry of Healthcare of the Russian Federation, Moscow, Russia.
  • Keltai M; Hungarian Cardiovascular Institute, Semmelweis University, Budapest, Hungary.
  • Ertl G; Hungarian Cardiovascular Institute, Semmelweis University, Budapest, Hungary.
  • Stoerk S; Deutsches Zentrum für Herzinsuffizienz, Medizinische Klinik I, Universitätsklinikum Würzburg, Würzburg, Germany.
  • Dans AL; Deutsches Zentrum für Herzinsuffizienz, Medizinische Klinik I, Universitätsklinikum Würzburg, Würzburg, Germany.
  • Lanas F; College of Medicine, University of Philippines, Manila, Philippines.
  • Liang Y; Universidad de La Frontera, Division of Cardiology, Internal Medicine Department, Temuco, Chile.
  • Zhu J; Fuwai Hospital, CAMS & PUMC, Beijing, China.
  • Torp-Pedersen C; Dept of Clinical Medicine, University of Aalborg, Copenhagen, Denmark.
  • Maggioni AP; Dept of Clinical Medicine, University of Aalborg, Copenhagen, Denmark.
  • Commerford PJ; ANMCO Research Center, Heart Care Foundation, Florence, Italy.
  • Guzik TJ; Division of Cardiology, Department of Medicine, Groote Schuur Hospital and the University of Cape Town, Cape Town, South Africa.
  • Vanassche T; Department of Medicine, Jagiellonian University Medical College Krakow, Poland.
  • Verhamme P; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
  • O'Donnell M; Department of Cardiovascular Sciences, University Hospitals Leuven, Leuven, Belgium.
  • Tonkin AM; Department of Cardiovascular Sciences, University Hospitals Leuven, Leuven, Belgium.
  • Varigos JD; NUI Galway, Department of Medicine, Ireland.
  • Vinereanu D; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
  • Felix C; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
  • Kim JH; University of Medicine and Pharmacy Carol Davila; University and Emergency Hospital, Bucharest, Romania.
  • Ibrahim KS; Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito, Ecuador.
  • Lewis BS; Catholic University of Korea, Department of Medicine, Seoul, South Korea.
  • Metsarinne KP; Faculty of Medicine, Universiti Teknologi MARA, Selangor, Malaysia.
  • Aboyans V; Lady Davis Carmel Medical Center and the Ruth and Bruce Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
  • Steg PG; Division of Medicine, Turku University Hospital and University of Turku, Turku, Finland.
  • Hori M; Department of Cardiology, Dupuytren University Hospital & INSERM 1094, Limoges, France.
Eur Heart J Cardiovasc Pharmacother ; 8(8): 786-795, 2022 12 02.
Article in En | MEDLINE | ID: mdl-35383832

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stroke / Peripheral Arterial Disease / Myocardial Infarction Type of study: Clinical_trials / Diagnostic_studies Limits: Humans / Infant Language: En Journal: Eur Heart J Cardiovasc Pharmacother Year: 2022 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stroke / Peripheral Arterial Disease / Myocardial Infarction Type of study: Clinical_trials / Diagnostic_studies Limits: Humans / Infant Language: En Journal: Eur Heart J Cardiovasc Pharmacother Year: 2022 Type: Article